Posts by tag: immuno-oncology

How somatic variants are computationally translated into candidate neoantigens

Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service

Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies

Learn why a pathologist chose Genevia Technologies as their partner.